AS · est 2005OsloParent · 3 subsidiarieswas BO HOLDING AS →2008
Brreg · companies
Employees—
CEO · since—
Chair · since—
headcount series appears after two register changes
Roles from Brreg, shown for business contact only. No birth date is shown or exported (purpose limitation, GDPR Art. 6(1)(f)).
Brreg · company_people
NOK, amounts in thousands
| 2024 | 2025 | ||
|---|---|---|---|
| Revenue | |||
| Operating result | −175 | −1 923 | |
| Result before tax | 2 851 | ||
| Net result | 2 750 |
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | ||
|---|---|---|---|---|---|---|---|
| Revenue | |||||||
| Operating result | −1 039 | −508 | −175 | −1 923 | |||
| Result before tax | 2 851 | ||||||
| Net result | 2 750 |
Regnskapsregisteret · company_revenue · FY2025 (company)
register ledger · money
| 2026-07-28 | reg | accounts_filed: last_annual_accounts_year | 2024 -> 2025 |
No corporate shareholders recorded.
Aksjonærregisteret · company_ownership · both directions
| 2024 | 2025 | 2026 | |
|---|---|---|---|
| auditor SLM REVISJON AS 2026-06-23 | ● | ||
| accountant — |
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | |
|---|---|---|---|---|---|---|---|
| auditor SLM REVISJON AS 2026-06-23 | ● | ||||||
| accountant — |
Brreg · company_org_roles
No recorded tender wins.
Relevant open tenders — matched · NACE 70.200 ↔ CPVsubscribers sharpen matches with per-company keywords
open-tender matching (NACE ↔ CPV) awaits Intelligo's open-tenders view
Doffin/TED · company_tender_wins · 2026-08-14
No job ads on record in the last 12 months.
NAV Arbeidsplassen · company_job_ad_months
Group revenue kr 102.8MGroup net kr -13.7MTenders won 0Rolled up across the parent + 3 subsidiaries — Link Medical Research AS alone is kr 60.8M.
rollup estimate · filed konsernregnskap not yet in Intelligo
| Link Medical AS | 100% | Research and experimental development on natural sciences and engineering | kr 41.9M |
| Biomedical Visions AS | 100% | Business and other management consultancy activities | kr 136k |
| Link Medical Research AS | 100% | Research and experimental development on natural sciences and engineering | kr 60.8M |
| Bobcat Holding AS | 49.4% | ||
| Aurora Analytica AS | 45.4% | ||
| Pharma Nordic AS | 8.1% | ||
| Fornix AS | 4.0% | ||
| Caedo Oncology AS | 3.5% | ||
| Pitch40 AS | 1.5% | ||
| Performance Industries AS | 1.3% | ||
| Condalign AS | 0.6% | ||
| Sparebank 1 Ringerike Hadeland | 0.0% | ||
| Sparebank 1 Østlandet | 0.0% |
Aksjonærregisteret · company_ownership · both directions
This company's annual report has not been read yet. The filed figures above come from the accounts form; everything the board wrote around them is in the PDF, which is read on request.
Regnskapsregisteret (årsberetning) · company_annual_reports
registered 2006-01-12
Brreg · companies
register ledger · 1 event
| 2026-07-28 | reg | accounts_filed: last_annual_accounts_year | 2024 -> 2025 |
Skiwo · company_events